STSS

$1.75

$

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Next Earnings

2026-02-25

Beta

2.195

Average Volume

Market Cap

Last Dividend

CIK

0001737995

ISIN

US82003F3091

CUSIP

82003F309

CEO

Paul Kruger Danner

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Full Time Employees

55

IPO Date

2022-04-14

Status

Active

Latest News

Title Headline Publisher Date
Sharps Technology and BitGo Announce Collaboration to Advance Solana Treasury Strategy NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (“STSS” or the “Company”) (NASDAQ: STSS), a medical device company with a Solana (SOL) digital asset treasury strategy, and BitGo Bank & Trust, National Association (“BitGo”), the digital asset infrastructure company, today announced a strategic collaboration under which STSS will expand and further institutionalize its Solana treasury strategy through BitGo's services. As part of this arrangement, STSS intends to utilize BitGo's institutional-grade qualified custody through its OCC regulated entity, BitGo Bank & Trust, National Association. GlobeNewsWire 2026-02-05 07:00:00
Insider Selling: Sharps Technology (NASDAQ:STSS) Major Shareholder Sells $174,798.00 in Stock Sharps Technology, Inc. (NASDAQ: STSS - Get Free Report) major shareholder Saba Capital Management, L.P. sold 77,688 shares of the company's stock in a transaction dated Wednesday, January 14th. The stock was sold at an average price of $2.25, for a total transaction of $174,798.00. Following the completion of the sale, the insider directly owned 1,549,170 Defense World 2026-01-18 05:40:52
Sharps Technology Strengthens Market Confidence with Advisor Lock-Up Agreement NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) today announced that it has entered into a 90-day lock-up agreement with SOL Markets (the “Strategic Advisor”), pursuant to which SOL Markets has agreed to restrict sales of its advisory warrants and any underlying shares. The lock-up reflects strong conviction in STSS's execution roadmap and reinforces alignment between the parties. This comes after the company's recent announcement that its Board of Directors approved a share buyback program for up to $100 million. GlobeNewsWire 2026-01-16 07:00:00
Head to Head Review: MacroGenics (NASDAQ:MGNX) & Sharps Technology (NASDAQ:STSS) MacroGenics (NASDAQ: MGNX - Get Free Report) and Sharps Technology (NASDAQ: STSS - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, institutional ownership, earnings and risk. Earnings and Valuation This table compares MacroGenics and Defense World 2025-12-08 01:28:48

SEC Filings

Type Filing Date Accepted Date Link
8-K 2026-02-23 2026-02-23 View Filing
SC 13D/A 2026-02-13 2026-02-13 View Filing
4 2026-02-13 2026-02-13 View Filing
SC 13D 2026-02-13 2026-02-13 View Filing
3 2026-02-13 2026-02-13 View Filing
EFFECT 2026-01-30 2026-02-02 View Filing
SC 13G 2026-01-26 2026-01-26 View Filing
SC 13G/A 2026-01-23 2026-01-23 View Filing
4 2026-01-20 2026-01-20 View Filing
8-K 2026-01-16 2026-01-16 View Filing
8-K 2026-01-16 2026-01-16 View Filing
SC 13G/A 2026-01-15 2026-01-15 View Filing
SC 13G/A 2026-01-15 2026-01-15 View Filing
SC 13G 2026-01-15 2026-01-15 View Filing
4 2026-01-15 2026-01-15 View Filing
3 2026-01-15 2026-01-15 View Filing
424B3 2026-01-13 2026-01-13 View Filing
EFFECT 2026-01-08 2026-01-09 View Filing
S-3/A 2025-12-23 2025-12-23 View Filing
S-3/A 2025-12-23 2025-12-23 View Filing
8-K 2025-12-23 2025-12-23 View Filing
SC 13G 2025-12-22 2025-12-22 View Filing
10-Q 2025-11-14 2025-11-14 View Filing
SC 13G/A 2025-11-12 2025-11-12 View Filing
D 2025-10-31 2025-10-31 View Filing
S-3 2025-10-23 2025-10-23 View Filing
8-K 2025-10-15 2025-10-15 View Filing
8-K 2025-10-09 2025-10-09 View Filing
8-K 2025-10-07 2025-10-07 View Filing
4 2025-10-06 2025-10-06 View Filing
3 2025-10-06 2025-10-06 View Filing
8-K 2025-10-06 2025-10-06 View Filing
DEFA14A 2025-10-03 2025-10-03 View Filing
8-K 2025-09-29 2025-09-29 View Filing
DEF 14A 2025-09-23 2025-09-23 View Filing
S-3 2025-09-15 2025-09-15 View Filing
PRE 14A 2025-09-10 2025-09-10 View Filing
8-K 2025-09-02 2025-09-02 View Filing
424B5 2025-09-02 2025-09-02 View Filing
S-3MEF 2025-09-02 2025-09-02 View Filing
8-K 2025-09-02 2025-09-02 View Filing
4 2025-08-28 2025-08-28 View Filing
4 2025-08-26 2025-08-26 View Filing
4 2025-08-26 2025-08-26 View Filing
4 2025-08-26 2025-08-26 View Filing
4 2025-08-26 2025-08-26 View Filing
4 2025-08-26 2025-08-26 View Filing
4 2025-08-26 2025-08-26 View Filing
4 2025-08-26 2025-08-26 View Filing
8-K 2025-08-25 2025-08-25 View Filing
S-8 2025-08-22 2025-08-22 View Filing
SC 13G/A 2025-08-14 2025-08-14 View Filing
10-Q 2025-08-13 2025-08-13 View Filing
DEFR14A 2025-08-05 2025-08-05 View Filing
DEFR14A 2025-08-05 2025-08-05 View Filing
DEF 14A 2025-07-28 2025-07-28 View Filing
PRER14A 2025-07-18 2025-07-18 View Filing
8-K 2025-07-18 2025-07-18 View Filing
4 2025-07-18 2025-07-18 View Filing
8-K 2025-07-03 2025-07-03 View Filing
PRE 14A 2025-07-03 2025-07-03 View Filing
SC 13G/A 2025-06-06 2025-06-06 View Filing
8-K 2025-06-04 2025-06-04 View Filing
8-K 2025-05-22 2025-05-22 View Filing
SC 13G 2025-05-15 2025-05-15 View Filing
10-Q 2025-05-15 2025-05-15 View Filing
SC 13G 2025-05-07 2025-05-07 View Filing
8-K 2025-05-07 2025-05-07 View Filing
4 2025-05-06 2025-05-06 View Filing
3 2025-05-06 2025-05-06 View Filing
8-K 2025-05-06 2025-05-06 View Filing
8-K 2025-04-30 2025-04-30 View Filing
8-K 2025-04-30 2025-04-30 View Filing
8-K 2025-04-25 2025-04-24 View Filing
8-K 2025-04-18 2025-04-18 View Filing
10-K/A 2025-04-15 2025-04-15 View Filing
8-K 2025-04-14 2025-04-14 View Filing
8-K 2025-04-04 2025-04-04 View Filing
8-K 2025-04-03 2025-04-03 View Filing
8-K 2025-04-02 2025-04-02 View Filing
4 2025-04-01 2025-04-01 View Filing
8-K 2025-03-28 2025-03-28 View Filing
10-K 2025-03-27 2025-03-27 View Filing
DEFA14A 2025-03-20 2025-03-20 View Filing
8-K 2025-03-20 2025-03-20 View Filing
8-K 2025-03-14 2025-03-14 View Filing
DEF 14A 2025-02-11 2025-02-11 View Filing
EFFECT 2025-02-10 2025-02-10 View Filing
SC 13G 2025-02-05 2025-02-05 View Filing
SC 13G 2025-01-31 2025-01-31 View Filing
AW 2025-01-31 2025-01-31 View Filing
PRE 14A 2025-01-31 2025-01-31 View Filing
8-K 2025-01-30 2025-01-30 View Filing
POS AM 2025-01-29 2025-01-29 View Filing
AW 2025-01-29 2025-01-29 View Filing
424B4 2025-01-29 2025-01-29 View Filing
S-1MEF 2025-01-28 2025-01-28 View Filing
EFFECT 2025-01-28 2025-01-28 View Filing
S-1/A 2025-01-27 2025-01-27 View Filing
S-1/A 2025-01-27 2025-01-27 View Filing

Algorithm Performance

Upgrade To Premium for Full Access
Algorithm Profit/Loss Profit Factor # Trades Sharpe Sortino Efficiency
Quantum Inspired Strategy 33.37% 1.14 18 0.71 0.5 40.7
Williams PercentR Strategy 12.81% 1 21 0.35 0.09 20.14
Neural Forcast 10.26% 1.48 20 0.4 54.08 17.59
xxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxx
xxxxxxxxxxxxx xxxxxxx% x x xxxx xxxx xxx
xxxxxxxxx xxxxxxx% x x xxxx xxxx xxxx
xxxx xxxxxxx% xxxx xx xxxx xxxx xxx
xxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxxx xxxx xxxx
xxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxx xxxx
xxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxx xxxxxxx% x xx xxxx xxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx x xxxx xxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx x
xxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx x
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx x
xxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxx xxxxxxx% x x xxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxx
xxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxx xxxx% xxxx xx xxxx x xxxx
xxxxxxxxxxxxx xxxxxx% x x xxxx xxx xxxx
xxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx x xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxx xxxxxx% xxxx x xxxx xxxx xxxx
xxxxxxxxx xxxxxx% x xx xxxx xxxx xxxx
xxxxxxxxxx xxxxxx% x xx xxxx xxxx xxx
xxxxxxxxxxxxxxxxxxxxx xxxxxx% x xx xxxx xxx xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% x xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% x xx xxxx x xxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% x xx xxxx x xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xx xxxx xxx xxx
xxxxxxxxxxxxxxxxxxxxxx xxxxxx% x xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% x xx xxxx x xxxx
xxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxx xxxxxx% x x xxxx xxxx xxxx
xxxxxxxxx xxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% x xx xxxx xxxx xxxx
xxxxxxxxxxxxxx xxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xx xxxx xxx x
xxxxxxxxxx xxxxxx% xxxx xx xxxx xxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xx xxxx xxx x
xxxxxxxxxxxxx xxxxxx% xxxx xx xxxx xxx x
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xx x xxxx xxxx
xxxxxxxxxxxx xxxxx% x x xxxx xxx xxxx
xxxxxxxxxxxxxxxxxxxxxx xxxxxx% x xx xxxxx xxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xx xxxx xxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxx xx xxxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx x xxxx xxxx xxx
xxx xxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxx xxxxx% xxxx xx xxxxx xxxx xxxx
xxxx xxxxxx% xxxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xx xxxxx xxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% x xx xxxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% x xx xxxxx xxx xxx
xxxxxxxxx xxxxxx% x xx xxxxx xxxx xxx
xxxxxxxxxxxxxxxxxxxxxxxxxx xxxxx% x xx xxxxx x xxxx
xxxxxxxxxxxxxxxxxx xxxxx% x x xxx xxxx xxxx
xxxxxxxxxxxx xxxx% xxxx x xxxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxx x% x x x x xxxx
xxxxxxxxxx x% x xx x x xxxx
xxxx x% x xx x x xxxx
xxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxx
xxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxx
xxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxx x% x x x x xxxx
xxxxxxxxxxxxxxxxxx x% x x x x xxxx
xxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxx
xxxxxxxxxxxxxxxxxxxxx x% x x x x xxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxx x% x xx x x xxxx
xxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxx x% x xx x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxx
xxxxxxxxxxxxxxxxxxxxxxx x% x x x x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xx xxxx xxxxx xxxx
xxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xx xxxxx xxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxx x xxxx
xxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx x
xxxx xxxxxxxx% xxxx xx xxxxx xxxxx x
xxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxx
xxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxx
xxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx